Analytica 2014 Tuesday Afternoon Sessions
International Congress Center Munich (ICM) Room 2
Session Title: Imaging Technologies
Session chaired by Professor Hoffmann
12:00 — Axel Walch:MALDI Molecular Imaging of Proteins, Metabolites and Drugs for Preclinical and Clinical Research 12:30 — Pavel Hozak:Imaging in Search for new Functions of Nuclear Phospholipids
Session Title: Metabolomics
Session chaired byProfessor Xu
14:00 — Guowang Xu:Metabolomics Should Pay Great Attention to Standard Operating Procedures 14:30 — Xianlin Han:Analyzing Thousands of Individual Cellular Lipid Species without HPLC Separation15:00 — Boguslaw Buszewski: Purification and Preconcentrationof Mycotoxins and its Metabolites by Molecularly Imprinted Adsorbents for Biomedical Analysis16:00 — Philipp Schmitt-Kopplin:The Need of Integrating Multiple Analytical Dimensions in Metabolomics 16:30 — Coral Barbas:Approaching Analytical Challenges in Metabolomics 17:00— Georgios Theodoridis: Metabolomics as a Tool for the Detection of Biomarkers of Physical Exercise17:30 — Matej Oresic:Analysis of Lipidomes in Health and Disease — a Systems Approach (Abstract)
International Congress Center Munich (ICM) Room 3
Session Title: The new Challenge in Water Analysis: Metabolites, Transformation Products and Non-Target Analysis
Session chaired by Professor Schmidt
12:00 — Wolfgang Schulz:The new Challenge in Water Analysis: Transformation Products and Non-Target Analysis in Combination with Effect Directed Analysis12:30 — Arne Wick:The Challenge of Identification and Quantification of Transformations Products in the Water Cycle13:00 — Damia Barceló — Identification of new Transformation Products of Selected Antibiotics formed during Advanced Oxidation, Photolysis and Enzymatic Wastewater Treatment Processes by on-line Turbulent Flow Liquid-Chromatography-LTQ-Orbitrap MS
Session Title: Service to Mankind: The Changing Faces of Analytical Chemistry
Session chaired by Professor Sweedler and Professor Nießner
14:00 — Jonathan Sweedler:The Evolving Frontiers of Analytical Chemistry14:30 — Bob Kennedy: The Nanoliter Lab: Using Droplet Microfluidics for High-Throughput Chemical Analysis15:00 — Dan Armstrong: Ionic Liquids in Separations and Mass Spectrometry16:00 — Francis Ligler: Hydrodynamic Focusing for Biosensors and Biomaterials Fabrication 16:30 — Yoshi Baba:Nano- and Quantum-Biodevices for Cancer Diagnosis, Cancer Therapy, and iPS Cell Based Regenerative Medicine17:00 — John Yates:Driving Biological Discovery Using Mass Spectrometry
International Congress Center Munich (ICM) Room 4a
Session Title: Miniaturized Analytical Systems
Session chaired by Professor Belder
12:00 — Petra S. Dittrich:Microchambers and Microdroplets: New Perspectives for Proteomics and Single-Cell Analysis12:30 — Gerald Urban: Pathogen Analysis on Chip: Sample Enrichment, Preparation and Detection 13:00 — Richard Moseley:Development of a Miniaturized Quadrupole Mass Spectrometer
Session Title: Autoantikörper gegen G-Protein gekoppelte Rezeptoren und Herz-Kreislauf-Krankheiten Chemistry
Session chaired by Professor Schimke
14:00 —Gerd Wallukat: Autoantikörper gegen G-Protein gekoppelte Rezeptoren bei Herz-Kreislauf-Krankheiten: Historischer Hintergrund und Prävalenz14:30 — Viacheslav Nikolaev: Analytik von Autoantikörpern gegen G-Protein gekoppelte Rezeptoren 15:00 — Fritz Boege:Autoantikörper in ihren molekularen Wechselwirkungen mit G-Protein gekoppelten Rezeptoren am Beispiel von beta1-Rezeptor-Autoantikörpern: Änderung von Rezeptorkonformation, -aktivität und –internalisierung als pathogene Stimuli bei Dilatativer Kardiomyopa16:00 — Roland Jahns: Tierexperimenteller Nachweis der Pathogenität von Autoantikörpern gegen G-Protein gekoppelte Rezeptoren am Beispiel von beta1-Rezeptor-Autoantikörpern und Dilatativer Kardiomyopathie16:30 — Rudolf Kunze: Therapeutische Apherese von Autoantikörpern gegen G-Protein gekoppelte Rezeptoren: Technologie und Nutzen17:00 — Ingolf Schimke:Therapiestrategien zur in vivo Neutralisation von Autoantikörpern gegen G-Protein gekoppelte Rezeptoren. Was kann die Zukunft bringen?
International Congress Center Munich (ICM) Room 5
Session Title: Aerosol and Health: A Challenge for Chemical and Biological Analysis
Session chaired by Professor Zimmermann
12:00 — James Schauer:Elucidating the Role of the Chemistry of Inhaled Aerosols to the Biological Pathways Leading to Adverse Health Effects 12:30 — Yoshitru Iinuma: Secondary Organic Aerosol Analysis: Achievements, Challenges and Opportunities14:00 — John G. Watson: Advances in Multi-Sample Characterization of Carbonaceous and Optical Properties in Atmospheric Aerosols 14:30 — Markus Kalberer: Quantification of Health-Relevant Aerosol Components: Development of Novel Analytical Techniques15:00 — Zoran Ristovski: Measurements of Oxidative Capacity of Combustion Generated Nanoparticles using Profluorescent Nitroxide Probes16:00 — Ian Gilmour:Comparative Chemistry and Toxicity of Emissions from Biodiesel and Biomass Combustion Sources16:30 — Barbara Rothen-Rutishauser:Combining 3D Lung Cultures and Aerosol Exposures at the Air-Liquid Interface – a new Generation of Realistic Risk Assessment Systems 17:00 — Per Schwarze:Effects of Complex Mixtures of Chemicals: Emphasis on Extracts from Diesel Exhaust Particles17:30 — Maria Antiñolo:Redox-Cycling Activity and Peroxides in Atmospheric Particles: Their Relationship to Aerosol Composition
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Multivariate Design of Experiments for Gas Chromatographic Analysis
November 1st 2024Recent advances in green chemistry have made multivariate experimental design popular in sample preparation development. This approach helps reduce the number of measurements and data for evaluation and can be useful for method development in gas chromatography.